CTKB

Cytek Biosciences Stock Analysis

AI Rating

Fair
  • Quality2/10
  • Growth↓ 2/10
  • Value↓ 1/10
Cytek Biosciences sales and earnings growth
CTKB Growth
Fair
  • Revenue Y/Y↓ 3.61%
  • EPS Y/Y↓ -533.33%
  • FCF Y/Y↓ -171.45%
Cytek Biosciences gross and profit margin trends
CTKB Profitability
Fair
  • Gross margin ↑ 51.70%
  • EPS margin↓ -36.20%
  • ROIC 5Y↓ -5.62%
Cytek Biosciences net debt vs free cash flow
CTKB Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -72.5

Cytek Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Medical Devices stocks